Hims & Hers CFO sells 54,927 shares, exercises options
Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe reported option exercises and share sales under a pre-arranged Rule 10b5-1 trading plan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. Chief Financial Officer Oluyemi Okupe reported option exercises and share sales under a pre-arranged Rule 10b5-1 trading plan. On April 16–17, Okupe sold a total of 54,927 shares of Class A Common Stock in open-market transactions at average prices of $25.8964 and $27.8344. He also exercised stock options for 6,184 shares at an exercise price of $5.01 per share, converting derivative awards into common stock. Following these transactions, Okupe holds 270,046 shares directly and 7,853 shares indirectly through the Oluyemi Okupe Separate Property Trust, and retains stock options representing 129,403 shares expiring on February 23, 2032.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 6,184 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 6,184 | $5.01 | $31K |
| Sale | Class A Common Stock | 18,005 | $27.8344 | $501K |
| Sale | Class A Common Stock | 36,922 | $25.8964 | $956K |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (4)
- F1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
- F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.74-$26.29. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $27.70-$27.97. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4. 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Stock Option (right to buy) financial
average weighted price financial
Separate Property Trust financial
vesting financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did HIMS CFO Oluyemi Okupe report on this Form 4?
Were the HIMS CFO’s stock sales made under a Rule 10b5-1 trading plan?
What stock options did the Hims & Hers CFO exercise in this Form 4?
What option position does the HIMS CFO retain following the reported exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.